Lan Deng

Lan Deng is currently the Director of Regulatory Affairs USA at Gracell Biotechnologies, where they lead U.S. regulatory development strategies and oversee submissions for clinical trial protocols. They previously held positions as Associate Director of Regulatory Affairs at AstraZeneca and Acting Director of R&D at The Whiteoak Group, Inc., focusing on regulatory submissions and drug product development. Lan earned a Ph.D. in Biology from New Jersey Institute of Technology and holds a certificate in Pharmaceuticals Regulatory Affairs from the Regulatory Affairs Professionals Society. Their early experiences include research and internships at institutions like Fudan University and the Shanghai Institute of Medical Materia.